Zhende Medical Co., Ltd.

SSE:603301.SS

20.83 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 991.5651,138.4961,082.971,066.099963.887917.849903.0551,005.6631,300.4771,940.0921,430.5111,502.2271,264.8051,228.924950.542917.5691,994.5372,281.8854,296.823,110.701709.14582.465523.19428.107333.965400.772363.006385.124279.954359.497335.918318.359292.669
Cost of Revenue 651.677776.984717.223721.481628.16587.334602.166667.645837.4661,187.007958.455994.295851.748805.876631.817638.4911,242.9541,169.5312,276.5911,657.845410.734393.253347.536291.099236.933262.864241.745276.124199.998249.252240.342218.705211.605
Gross Profit 339.888361.512365.748344.618335.728330.515300.889338.019463.01753.085472.056507.932413.056423.049318.725279.077751.5831,112.3542,020.2291,452.856298.406189.212175.654137.00897.032137.909121.261109.00179.957110.24695.57699.65381.063
Gross Profit Ratio 0.3430.3180.3380.3230.3480.360.3330.3360.3560.3880.330.3380.3270.3440.3350.3040.3770.4870.470.4670.4210.3250.3360.320.2910.3440.3340.2830.2860.3070.2850.3130.277
Reseach & Development Expenses 33.48436.61736.42131.54429.49428.49928.19940.15442.09466.3961.87965.82132.91447.60531.29623.51250.72893.08693.42658.5814.6217.39211.01812.6479.89717.34518.62734.3657.51712.93710.77119.9490
General & Administrative Expenses 134.01-269.859323.634-54.517125.808-251.769301.167-62.385132.274-220.053301.59-62.792121.611-164.466241.412-86.378155.995-110.70999.318-32.51482.926-84.7757.468-13.45232.561-58.86431.818-19.09829.873-54.12927.62537.19930.544
Selling & Marketing Expenses 90.949-69.433172.08989.70288.96393.20971.811100.151116.084143.302118.854114.308100.4988078.05630.657178.043110.298219.72182.78179.67561.45848.89842.435.15433.82331.64231.84720.48621.36223.08423.5121.363
SG&A 224.96-339.292495.723203.113214.771-158.56372.97837.766248.358-76.751420.44451.517222.109-84.466319.468-55.722334.039-0.411319.03850.266162.6-23.313106.36628.94867.715-25.04163.4612.74950.359-32.76850.70960.70951.907
Other Expenses 18.936568.278-361.026-6.995-0.737-2.012-2.592-0.2917.329380.743-248.024185.3920.063-1.4090.366-1.6690.687-3.311-0.36-4.629-0.804-1.730.096-0.3970.061-1.828-0.196-4.4440.236-0.347-0.150.4320.112
Operating Expenses 277.38265.603171.118241.651240.737251.82217.413220.778297.781370.381234.299302.729255.086229.676190.581108.629390.312343.757409.741208.107172.59599.032117.05891.70254.91463.04379.63981.61342.96345.00356.84662.7245.708
Operating Income 62.50895.91194.63102.96785.774-105.59267.43590.388173.717295.526202.896175.005139.382153.286145.844158.901363.941637.1871,578.8431,216.433104.54778.92248.36237.83335.21652.39638.1838.79824.04359.3232.99829.30926.211
Operating Income Ratio 0.0630.0840.180.0970.089-0.1150.0750.090.1340.1520.1420.1160.110.1250.1530.1730.1820.2790.3670.3910.1470.1350.0920.0880.1050.1310.1050.1010.0860.1650.0980.0920.09
Total Other Income Expenses Net -1.114-1.27-11.6349.821-0.737-2.012-2.592-0.291-2.161-5.4270.206-2.841-3.032-1.4090.366-1.6690.687-3.311-0.360.551-0.804-1.0590.096-1.340.061-1.828-0.196-0.0720.236-0.347-0.15-0.2580.112
Income Before Tax 61.39494.639182.996113.15385.036-107.60464.84390.098171.556290.1203.103172.164136.35151.878146.211157.233364.628633.8761,578.4841,216.984103.74377.86348.45837.63835.27750.56937.98438.72624.27958.97332.84829.21426.323
Income Before Tax Ratio 0.0620.0830.1690.1060.088-0.1170.0720.090.1320.150.1420.1150.1080.1240.1540.1710.1830.2780.3670.3910.1460.1340.0930.0880.1060.1260.1050.1010.0870.1640.0980.0920.09
Income Tax Expense 8.98614.90332.80920.739.806-12.259-1.072-4.74823.57150.05918.55210.75319.3416.52613.59314.57654.30771.948272.93199.12217.1875.3436.6426.5384.135.9984.8376.2824.5628.8027.2184.8664.358
Net Income 51.24277.71146.35187.71173.398-102.12263.15590.905146.461226.089183.469159.702111.872113.332104.326124.032254.172451.71,109.185902.65685.91361.77835.00729.4930.61544.94833.15332.39619.70749.87125.59924.27222.028
Net Income Ratio 0.0520.0680.1350.0820.076-0.1110.070.090.1130.1170.1280.1060.0880.0920.110.1350.1270.1980.2580.290.1210.1060.0670.0690.0920.1120.0910.0840.070.1390.0760.0760.075
EPS 0.190.290.550.330.28-0.370.240.340.550.850.810.710.50.60.460.551.122.275.574.580.440.320.180.210.160.330.170.220.130.340.170.160.15
EPS Diluted 0.190.290.550.330.28-0.370.240.340.550.850.80.70.490.590.460.551.122.275.184.580.40.320.180.210.160.330.170.220.130.340.170.160.15
EBITDA 66.899.445190.523190.399163.145-39.436133.887158.821239.482339.8214.414235.335196.773199.047189.765200.128399.444655.9361,585.9671,228.702116.31198.73655.80358.48260.0551.99344.70839.79737.20263.01440.43439.5248.449
EBITDA Ratio 0.0670.0870.1760.1790.169-0.0430.1480.1580.1840.1750.150.1570.1560.1620.20.2180.20.2870.3690.3950.1640.170.1070.1370.180.130.1230.1030.1330.1750.120.1240.166